GeneDx Holdings Corp. (NASDAQ:WGSWW – Get Free Report) saw a significant decrease in short interest during the month of July. As of July 15th, there was short interest totaling 18,319 shares, a decrease of 64.1% from the June 30th total of 50,980 shares. Based on an average daily volume of 59,199 shares, the days-to-cover ratio is presently 0.3 days.
GeneDx Price Performance
NASDAQ:WGSWW opened at $0.00 on Wednesday. GeneDx has a 12-month low of $0.00 and a 12-month high of $0.13.
GeneDx Company Profile
GeneDx is a molecular diagnostics company specializing in high-complexity genetic testing for rare and ultra-rare inherited disorders. The company leverages next-generation sequencing (NGS) technologies, including whole exome sequencing, targeted gene panels, and chromosomal microarray analysis, to deliver comprehensive diagnostic insights. Its services are designed to support clinicians in identifying genetic mutations that underlie pediatric and adult conditions, guiding patient management, treatment decisions, and genetic counseling.
Founded in 2000 by Dr.
Featured Stories
- Five stocks we like better than GeneDx
- Welltower at 52-Week Highs—But Analysts Believe There’s More to Come
- D-Wave’s AT&T Deal Shows Quantum Computing Is Moving Beyond Theory
- Insiders Sell, Institutions Buy: The AI Trade Is Getting More Interesting
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
Receive News & Ratings for GeneDx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneDx and related companies with MarketBeat.com's FREE daily email newsletter.
